Franck Emmanuel Nicolini

7PUBLICATIONS
20CO-AUTHORS
Liquid biopsiesPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 05, 2025
Management of chronic myeloid leukemia in 2025.

Hagop Kantarjian, Massimo Breccia, Fadi G Haddad

|Nov 07, 2024
Clinical outcomes in patients in any phase of CML treated with ponatinib in France-Data from the TOPASE observational study.

F Huguet, A Guerci-Bresler, G Roth-Guepin

|May 28, 2024
Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phase.

Fadi G Haddad, Koji Sasaki, Lewis Nasr

|Feb 07, 2024
Kinetics of molecular recurrence after tyrosine kinase inhibitor cessation in chronic phase chronic myelogenous leukaemia patients.

Vincent Alcazer, Stéphane Morisset, Delphine Rea

|Apr 02, 2023
Efficacy and safety of nilotinib in chronic myeloid leukaemia patients who failed to achieve a treatment-free remission period after imatinib discontinuation: Results of the French Nilo post-STIM study.

Stéphanie Dulucq, Françoise Rigal-Huguet, Franck E Nicolini

|Oct 10, 2022
Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA-PegIFN study).

Lydia Roy, Jean-Claude Chomel, Joëlle Guilhot

Pageof 2

Frequent Collaborators

4 joint publications

Gabriel Etienne

3 joint publications

Delphine Rea

2 joint publications

Emilie Cayssials

2 joint publications

Lydia Roy